Royalty Pharma Sub-Manager specializes in managing investments in royalty interests related to pharmaceutical, biopharmaceutical, medical, and healthcare products. They advise private funds and a public company, tailoring their services to the specific investment goals of each client. The firm focuses on acquiring or investing in revenue-producing royalty interests, providing liquidity to royalty owners, and funding late-stage clinical development in exchange for future royalties.
Fee Structure
Royalty Pharma Sub-Manager receives compensation from its clients in the form of an operating and personnel expense fee, which is either a flat fee or determined on a cost-plus basis. The firm and an entity controlled by its CEO also receive performance-based compensation from some clients. The specific terms are detailed in the governing documents of each client.